The GLP-1 Benchmark Report: A Data-Driven Guide to Building a Strategy That Delivers Outcomes and Cost Savings
Summary
25 million Americans are expected to be on a GLP-1 by 2030, and most employers already have coverage decisions in place. Few, however, have a strategy they can defend.
U.S. GLP-1 spending reached $132 billion in 2025, and 79% of employers are seeing higher utilization of obesity medications. Yet only about 1 in 3 people are still on therapy at one year, and over half of the weight comes back within 12 months of stopping. Costs are continuing to climb while results fade and downstream cost savings never materialize.
Noom Health’s GLP-1 Benchmark Report gives benefits leaders the numbers and the framework to close that gap, including the four decisions to make before launch. Download the report for GLP-1 coverage benchmarks, cost projections, the clinical evidence for pairing medication with behavior change, and see how a structured, clinically-integrated GLP-1 strategy with Noom Med plus SmartRx can deliver millions in real savings without compromising access or outcomes.
Download the White Paper
"*" indicates required fields
By submitting this form, I understand that Noom will process my personal information in accordance with their Privacy Policy.
Related Content
Bring Noom to
your organization
Give your workforce a preview of what’s possible
for their physical and mental health.